Famitinib Combined With SHR-A1811, Versus SHR-A1811 for CDK4/6 Inhibitors-resistent Advanced HR+/HER2- Breast Cancer With SNF4 Subtype
Clinical trial NCT07382687 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07382687
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-26
- Primary completion
- 2028-12-31
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.